Results 91 to 100 of about 22,201 (271)

Potentially addictive substances among patients in opioid agonist therapy : - dispensations, use, and fatigue - [PDF]

, 2021
Background The current opioid epidemic is a major cause of suffering and overdose deaths globally. It can interact with patients’ general well-being and causes fatigue.
Vold, Jørn Henrik
core  

Investigation of eosin Y as a colorimetric sensor for the detection of fentanyl hydrochloride and fentanyl freebase

Journal of Forensic Sciences, EarlyView.
Abstract The increasing prevalence of fentanyl within the illegal global drug market underscores the need for rapid, low‐cost, and straightforward detection methods. Eosin Y demonstrates a measurable color change in the presence of fentanyl, making it a promising candidate for colorimetric sensing and preliminary identification of fentanyl ...
Alan J. Zhou, Melissa M. Dixon, Brady S. Gentle, Genevieve H. Dennison, Kellie L. Tuck   +4 more
wiley   +1 more source

Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa

Addiction Science & Clinical Practice, 2020
Background Emerging data points to a potential heroin use epidemic in South Africa. Despite this, access to methadone maintenance therapy and other evidence-based treatment options remains negligible.
Andrew Scheibe, Shaun Shelly, Tara Gerardy, Zara von Homeyer, Andrea Schneider, Kalvanya Padayachee, Shalon Balaguru Naidoo, Klaas Mtshweni, Ayanda Matau, Harry Hausler, Monique Marks   +10 more
doaj   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

A Retrospective Study of Acute Postoperative Pain After Cesarean Delivery in Patients With Opioid Use Disorder Treated With Opioid Agonist Pharmacotherapy

, 2022
OBJECTIVE: We aimed to quantify the effect of opioid agonist pharmacotherapy on pain management after cesarean delivery, compared with patients not on these medications.
Cobb, Johanna, Warters, Robert, Quaye, Aurora, Turcotte, Heather, Richard, Janelle, Craig, Wendy, Snow, Elizabeth   +6 more
core  

Buprenorphine-based opioid substitution therapy in India: A few observations, thoughts, and opinions

Indian Journal of Psychiatry, 2018
The most evidence-based treatment for opioid dependence is opioid agonist maintenance treatment also known as opioid substitution therapy (OST). However, there are some critical, yet unaddressed issues of buprenorphine-based substitution therapy ...
Abhishek Ghosh, Debasish Basu, Ajit Avasthi   +2 more
doaj   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review

Systematic Reviews, 2019
Background Opiate agonist therapy (OAT) prescribing rates by family physicians are low in the context of community-based, comprehensive primary care. Understanding the factors that support and/or inhibit OAT prescribing within primary care is needed. Our
Lara L. Nixon, Jazmin C. Marlinga, K. Alix Hayden, Kelly J. Mrklas   +3 more
doaj   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies

, 2021
Background and Objectives: Patients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative
Jennifer D. Ellis, Meagan M. Carr, Saules, Karen K., David M. Ledgerwood, Staples, Angela, Karen K. Saules, Carr, Meagan M., Angela Staples, Jamie L. Page, Page, Jamie L., Ledgerwood, David M., Ellis, Jennifer D.   +11 more
core   +1 more source